With the principals having previously woring with/for with Novartis and Google Brain and coming out of Harvard and MIT., Syllable describes itself as a data science company specializing in behavioral phenotyping. Describing themselves as decoding behavior with Artificial Intelligence, by analyzing motions, the objective is to develop behavioral insights that c/would support improvement of human health and patient care. The effort is to use machine learning and computer vision automatically to decipher body language in humans and laboratory animals. The firm's system is being used successfully to classify drugs. In partnership with two large pharmaceutical companies the systemis ebing employed help make better drugs for movement disorders like Lou Gehrig's disease, and neurodegenerative diseases like Parkinson's and Alzheimer's.
